Characterization of a partially protective B-cell epitope within the 62 kDa antigen of Schistosoma japonicum

Acta Biochimica et Biophysica Sinica

Volumn 39, Issue 10, 2007, Pages 770-778

  Zhang, Lei ^a,d   Yang, Xue ^a   Yang, Yanfen ^a   Zhao, Jiaqing ^a,c   Yang, Jianghua ^a,b   Liu, Feng ^a   Zhang, Zhaosong ^a   Wu, Guanling ^a   Su, Chuan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

^d GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

B cell epitope; Characterization; Schistosoma japonicum; Sj62

Indexed keywords

EPITOPE; HELMINTH PROTEIN; PARASITE ANTIGEN; PEPTIDE FRAGMENT; SJ62 PROTEIN, SCHISTOSOMA JAPONICUM; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; FEMALE; IMMUNOLOGY; MOUSE; PREDICTION AND FORECASTING; SCHISTOSOMA JAPONICUM;

ANIMALS; ANTIGENS, HELMINTH; EPITOPES, B-LYMPHOCYTE; FEMALE; HELMINTH PROTEINS; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SCHISTOSOMA JAPONICUM;

ANIMALIA; MURINAE; MUS; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI;

EID: 35448957308     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2007.00340.x     Document Type: Article

References (31)

1. McManus DP, Bartley PB. A vaccine against Asian schistosomiasis. Parasitol Int 2004 53 : 163 173.
2. Bergquist NR, Leonardo LR, Mitchell GF. Vaccine-linked chemotherapy: Can schistosomiasis control benefit from an integrated approach Trends Parasitol 2005 21 : 112 117.
3. Engers HD, Bergquist R, Modabber F. Progress on vaccines against parasites. Dev Biol Stand 1996 87 : 73 84.
4. Soisson LM, Masterson CP, Tom TD, McNally MT, Lowell GH, Strand M. Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J Immunol 1992 149 : 3612 3620.
5. Soisson LA, Strand M. Schistosoma mansoni: Induction of protective immunity in rats using a recombinant fragment of a parasite surface antigen. Exp Parasitol 1993 77 : 492 494.
6. Soisson LA, Reid GD, Farah IO, Nyindo M, Strand M. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent. J Immunol 1993 151 : 4782 4789.
7. Zhang Y, Taylor MG, Bickle QD. Schistosoma japonicum myosin: Cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5. Parasite Immunol 1998 20 : 583 594.
8. Verjovski-Almeida S, DeMarco R, Martins EA, Guimaraes PE, Ojopi EP, Paquola AC, Piazza JP et al. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nature Genet 2003 35 : 148 157.
9. El-Sayed NM, Bartholomeu D, Ivens A, Johnston DA, LoVerde PT. Advances in schistosome genomics. Trends Parasitol 2004 20 : 154 157.
10. Korber B, LaBute M, Yusim K. Immunoinformatics comes of age. PLoS Comput Biol 2006 2 : e71.
11. Beaver JE, Bourne PE, Ponomarenko JV. EpitopeViewer: A Java application for the visualization and analysis of immune epitopes in the Immune Epitope Database and Analysis Resource (IEDB). Immunome Res 2007 3 : 3.
12. Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 1999 112 : 531 552.
13. Holzhutter HG, Kloetzel PM. A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates. Biophys J 2000 79 : 1196 1205.
14. Li YS, Ross AG, Sleigh AC, Li Y, Waine GJ, Williams GJ, Tanner M et al. Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China. Acta Trop 1999 73 : 79 92.
15. Aral C, Akbuga J. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes. J Pharm Pharm Sci 2003 6 : 321 326.
16. Liu G, Molas M, Grossmann GA, Pasumarthy M, Perales JC, Cooper MJ, Hanson RW. Biological properties of poly-L-lysine-DNA complexes generated by cooperative binding of the polycation. J Bio Chem 2001 276 : 34379 34387.
17. Li Y, Auliff A, Jones MK, Yi X, McManus DP. Immunogenicity and immunolocalization of the 22.6 kDa antigen of Schistosoma japonicum. Parasite Immunol 2000 22 : 415 424.
18. Waine GJ, Mazzer DR, McManus DP. Production of IgE antibodies against the 22 kDa tegumental membrane-associated antigen of schistosomes is directed by the antigen itself. Parasite Immunol 1997 19 : 531 533.
19. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad of Sci USA 1981 78 : 3824 3828.
20. Zhu Y, Ren J, Da'dara A, Harn D, Xu M, Si J, Yu C et al. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine 2004, 23 : 78 83.
21. Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 1978 47 : 45 148.
22. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986 25 : 5425 5432.
23. Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985 55 : 836 839.
24. Arnon R. Synthetic peptides as the basis for vaccine design. Mol Immunol 1991 28 : 209 215.
25. Li GF, Wang Y, Zhang ZS, Wang XJ, Ji MJ, Zhu X, Liu F et al. Identification of immunodominant Th1-type T cell epitopes from Schistosoma japonicum 28 kDa glutathione-S-transferase, a vaccine candidate. Acta Biochim Biophys Sin 2005 37 : 751 758.
26. MacDonald AS, Straw AD, Bauman B, Pearce EJ. CD8- dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001 167 : 1982 1988.
27. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994 179 : 1109 1118.
28. Jankovic D, Wynn TA, Kullberg MC, Hieny S, Caspar P, James S, Cheever AW et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-γ-dependent effector mechanisms. J Immunol 1999 162 : 345 351.
29. Caulada-Benedetti Z, al-Zamel F, Sher A, James S. Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J Immunol 1991 146 : 1655 1660.
30. Anderson S, Coulson PS, Ljubojevic S, Mountford AP, Wilson RA. The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells. Immunology 1999 96 : 22 28.
31. Tarrab-Hazdai R, Schechtman D, Arnon R. Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni. Infect Immun 1998 66 : 4526 4530.